{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-021658","form_type":"8-K","ticker":"CURX","cik":"0002025942","company_name":"Curanex Pharmaceuticals Inc","filed_at":"2026-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.400304+00:00","generated_at":"2026-05-14T22:06:01.163337+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Nasdaq grants CURX additional 180 days until Nov 2, 2026 to meet $1 bid price","bullets":["Received Nasdaq notice on Nov 5, 2025 for bid price below $1.00; initial 180-day period ended May 4, 2026.","Nasdaq granted second 180-day compliance period through Nov 2, 2026, based on meeting other listing requirements.","Company may implement a reverse stock split to cure the deficiency.","If bid price stays at $1.00 for 10 consecutive days during extension, compliance will be confirmed.","Failure to regain compliance by Nov 2, 2026 could result in delisting, with appeal rights."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-021658","json":"https://secwatch.observer/filing/0001493152-26-021658.json","markdown":"https://secwatch.observer/filing/0001493152-26-021658.md","text":"https://secwatch.observer/filing/0001493152-26-021658.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2025942/000149315226021658/0001493152-26-021658-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2025942/000149315226021658/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-14T22:06:01.163337+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}